Skip to main content
. 2021 Mar 2;10(5):985. doi: 10.3390/jcm10050985

Table 5.

Comparative efficacy between dulaglutide (DU) 1.5 mg/once weekly and liraglutide (LIRA) 1.2–1.8 mg/once daily as add-on to MET or MET plus conventional insulin secretagogues, after 18 months of continuous treatment.

Outcomes LIRA (N = 54) DU (N = 54) p Value
Body weight reduction ≥ 5% 15 (27.8%) 13 (24.1%) 0.827
HbA1c reduction ≥ 0.5% 32 (59.3%) 34 (63.0%) 0.987
HbA1c ≤ 7% 23 (42.6%) 35 (64.8%) 0.033

p values were calculated by using the Fisher’s exact test.